This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome.
Medical hypotheses, 68(5), 1144-6
Citation
Tsai, Shih-Jen. (2007). Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome.. Medical hypotheses, 68(5), 1144-6.